
Non-Small Cell Lung Carcinoma
NSCLC
patients
patient
non-small cell lung carcinoma
lung cancer
lung cancers
tumors
Lung cancer
small cell lung carcinoma
SCLC
adenocarcinoma
ADC
squamous cell carcinoma
SqCC
tumor
EGFR
epidermal growth factor receptor
EML4-ALK
EML4
ALK
LKB1
STK11
NF1
CDKN2A
SMARCA4
KEAP1
KRAS
ROS1
RET
DDR2
PTEN
MLL2
HLA-A
NFE2L2
NOTCH1
RB1
tyrosine
crizotinib
TKIs
EML4-ALK alterations
PD-L1
programmed cell death ligand 1
CD8
PD-1
hematoxylin
eosin
NSCLCs
lung tumors
EWSR1
CREB1
WWTR1
CAMTA1
bronchioloalveolar carcinoma
sclerosing hemangioma" to "sclerosing pneumocytoma", and "hamartoma" to "pulmonary hamartoma
NUT carcinoma", "pulmonary myxoid sarcoma
myoepithelioma and myoepithelial carcinomas
epithelioid hemangioendotheliomas
PEComatous tumors
malignant PEComa" and "lymphangioleiomyomatosis
advanced disease
cell carcinoma
lung ADC
necrosis
carcinomas lack
TTF-1
thyroid transcription factor-1
Napsin A
CK5/6
P63
P40
neoplasm of lung
thyroid tumors
neuroendocrine tumors
carcinoid tumors
renal cell carcinomas
N
pulmonary alveolar macrophages
CK5
TMA
SPATS2
ST6GALNAC1
Lung Tumors
gefitinib
Erlotinib
non-small-cell lung cancer
lung adenocarcinoma
squamous cell lung cancers
Thoracic Tumors
AKT
mTOR
non-small cell lung cancer
cancer
pulmonary squamous cell carcinoma and adenocarcinoma
staging
carcinoma
Napsin A and Thyroid Transcription Factor -1
Carcinomas of the Lung
Malignant Mesothelioma
CK7
adenocarcinoma and squamous cell carcinoma of the lung
Lung Adenocarcinomas
p40
p63
Thyroid transcription factor 1
napsin a
pulmonary non-small carcinomas into adenocarcinoma
Primary Squamous Cell Carcinoma
Adenocarcinoma
Small Cell Carcinoma of Lung
Napsin-A
non-small cell lung carcinomas
human
lung NSCLC
tumour
adenocarcinoma of the lung
ERBB2
HSP90
KIF5B
FGFR1
IGF1R
NRAS              <1
RASA1
AKT1
AKT3
MDM2
TP53
ERBB3
Gefitinib
Afatinib
Dacomitinib
Neratinib
Crizotinib
Ceritinib
Ganetispib
AT13387
Tivantinib
Cabozantinib
Crizotinib2
AMG102
Vandetanib
AZD4547
nintedanib
dovitinib
HGS1036
AXL1717
Selumetinib
Trametinib
everolimus,sirolimus AUY922
BYL719
Vemurafenib
GDC-0941
MK-2206
Everolimus
sirolimus
temsirolimus
Biguanide
PD0332991
BAY1000394
BH3
Overexpression              ND              ND
V600E
PD- 1
Bristol
